Clovertex’s Target of the Year 2024 is the Gastric Inhibitory Polypeptide Receptor (GIPR), which has...
Clovertex’s December Target of the Month is the Dystrophin-Glycoprotein Complex (DGC), inspired by a...
Clovertex’s November Target of the Month is Ninjurin 1 (NINJ1), selected in light of a recent cryo-E...
Following this year’s Nobel Prize in Chemistry for breakthroughs in protein structure prediction and...
We are pleased to announce that PTH1R (Parathyroid Hormone 1 Receptor) is Clovertex's Target of the ...
We are excited to announce that Isocitrate Dehydrogenase 1(IDH1) has been selected as Clovertex’s Ta...
We are excited to announce that Protective Antigen has been selected as Clovertex’s Target of the Mo...
We are excited to announce that CD38 has been selected as Clovertex’s Target of the Month for June. ...
This May's Clovertex Target of the Month is the FZD4 Receptor, a pivotal protein involved in Wnt sig...
This April's Clovertex Target of the Month is the Androgen Receptor (AR), a critical protein involve...